Description

4,8-Methano-1,3-Dioxolo[4,5-D]Oxepin-5-Ol,Hexahydro-2,2-Dimethyl-,[3Ar-(3A-α-,4-Bta-,5-α-,8-Bta-,8A-α-)]-(9Ci) is a complex, stereochemically defined bicyclic organic compound. This high-purity intermediate is valued for its unique fused ring structure, which makes it a critical building block in advanced synthetic chemistry. It is primarily sought after by research institutions and pharmaceutical companies for the development of novel active pharmaceutical ingredients (APIs) and other fine chemicals.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the multi-step synthesis of complex drug candidates, particularly those targeting the central nervous system.
• Asymmetric Synthesis: Utilized as a precursor or scaffold in catalytic asymmetric reactions to introduce specific stereocenters.
• Medicinal Chemistry Research: Serves as a core structure for constructing compound libraries in drug discovery and lead optimization programs.
• Fine Chemical Production: Employed in the manufacture of specialty chemicals, flavors, and fragrances requiring high stereochemical purity.
• Academic & Industrial R&D: Used in methodological studies and the development of new synthetic pathways in organic chemistry.

Basic Information

Product Name	4,8-Methano-1,3-Dioxolo[4,5-D]Oxepin-5-Ol,Hexahydro-2,2-Dimethyl-,[3Ar-(3A-α-,4-Bta-,5-α-,8-Bta-,8A-α-)]-(9Ci)
CAS No.	158413-31-1
Molecular Formula	C11H18O4
Molecular Weight	214.26 g/mol
Synonyms	Hexahydro-2,2-dimethyl-4,8-methano-1,3-dioxolo[4,5-d]oxepin-5-ol; (3aR,4S,5R,8S,8aR)-Hexahydro-2,2-dimethyl-4,8-methano-1,3-dioxolo[4,5-d]oxepin-5-ol; Bicyclic dioxolane-oxepin derivative; 158413-31-1; (3aR,4S,5R,8S,8aR)-2,2-Dimethylhexahydro-4,8-methano-1,3-dioxolo[4,5-d]oxepin-5-ol
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency and high chemical purity. Quality is verified through comprehensive analytical techniques including HPLC, GC, and NMR. A Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment. We support cGMP and ISO compliant manufacturing for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed under an inert atmosphere if specified. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Specific Rotation	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.